{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:30:13Z","timestamp":1790271013731,"version":"4.1.0"},"reference-count":33,"publisher":"The Endocrine Society","issue":"9","license":[{"start":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T00:00:00Z","timestamp":1555372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008392","name":"Sundhed og Sygdom, Det Frie Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["133-00283"],"award-info":[{"award-number":["133-00283"]}],"id":[{"id":"10.13039\/100008392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute of Health Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Oxford Biomedical Research Centre"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>The clinical phenotype of multiple endocrine neoplasia type 4 (MEN4) is undefined due to a limited number of published cases. Knowledge on disease manifestation in MEN4 is essential for developing prevention programs and treatment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To expand current knowledge of the MEN4 phenotype including assessment of penetrance.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>This is a case report and a brief review of previously published MEN4 cases.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Patients<\/jats:title>\n                  <jats:p>We report a large Danish family with multiple cases of endocrine tumors that segregated with a pathogenic variant in the CDKN1B gene.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main Outcome\/Result<\/jats:title>\n                  <jats:p>The medical history of the proband included primary hyperparathyroidism and Cushing disease. Genetic analysis identified a pathogenic variant in CDKN1B (c.121_122delTT, p.Leu41Asnfs*83). Among the family members, another 12 individuals were identified as carriers of the same variant, which segregated with development of endocrine tumors. Hypercalcemia due to primary hyperparathyroidism occurred in all 13 of the available carriers of the genetic variant, and 4 patients also had functioning or nonfunctioning pituitary adenomas, whereas 1 patient had a metastatic neuroendocrine tumor (carcinoid). Loss-of-heterozygosity was detected in two of five parathyroid adenomas, supporting that CDKN1B acts as a tumor suppressor gene. Thirty cases representing 16 different CDKN1B variants have previously been reported, and these cases presented primarily with primary hyperparathyroidism and functioning and nonfunctioning pituitary tumors.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Hypercalcemia due to primary hyperparathyroidism and pituitary tumors are common in MEN4. Gastrointestinal neuroendocrine tumors appear to be less prevalent in MEN4 than in MEN1.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/jc.2019-00082","type":"journal-article","created":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T09:03:23Z","timestamp":1555405403000},"page":"3637-3646","source":"Crossref","is-referenced-by-count":109,"title":["Clinical Features of Multiple Endocrine Neoplasia Type 4: Novel Pathogenic Variant and Review of Published Cases"],"prefix":"10.1210","volume":"104","author":[{"given":"Anja","family":"Frederiksen","sequence":"first","affiliation":[{"name":"Department of Clinical Genetics, University of Southern Denmark, Odense, Denmark"},{"name":"Department of Clinical Research, Faculty of Health, University of Southern Denmark, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Rossing","sequence":"additional","affiliation":[{"name":"Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pernille","family":"Hermann","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Odense University Hospital, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Ejersted","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Odense University Hospital, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh V","family":"Thakker","sequence":"additional","affiliation":[{"name":"Academic Endocrine Unit, Oxford Centre for Diabetes, Endocrinology & Metabolism, Radcliffe Department of Medicine, University of Oxford, Churchill Hospital, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5608-1589","authenticated-orcid":false,"given":"Morten","family":"Frost","sequence":"additional","affiliation":[{"name":"Department of Clinical Research, Faculty of Health, University of Southern Denmark, Odense, Denmark"},{"name":"Department of Endocrinology, Odense University Hospital, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2019,4,16]]},"reference":[{"issue":"9","key":"2019121022403582500_bib1","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"97","author":"Thakker","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2019121022403582500_bib2","first-page":"2617","article-title":"Multiple endocrine neoplasia--syndromes of the twentieth century","volume":"83","author":"Thakker","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"1-2","key":"2019121022403582500_bib3","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mce.2013.08.002","article-title":"Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4)","volume":"386","author":"Thakker","year":"2014","journal-title":"Mol Cell Endocrinol"},{"issue":"8","key":"2019121022403582500_bib4","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1210\/jc.2013-1204","article-title":"Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update","volume":"98","author":"Wells","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2019121022403582500_bib5","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/humu.20605","article-title":"Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene","volume":"29","author":"Lemos","year":"2008","journal-title":"Hum Mutat"},{"issue":"42","key":"2019121022403582500_bib6","doi-asserted-by":"crossref","first-page":"15558","DOI":"10.1073\/pnas.0603877103","article-title":"Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans","volume":"103","author":"Pellegata","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"2019121022403582500_bib7","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1210\/jc.2008-2083","article-title":"Rare germline mutations in cyclin-dependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related states","volume":"94","author":"Agarwal","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2019121022403582500_bib8","doi-asserted-by":"crossref","first-page":"e1003350","DOI":"10.1371\/journal.pgen.1003350","article-title":"A novel mutation in the upstream open reading frame of the CDKN1B gene causes a MEN4 phenotype","volume":"9","author":"Occhi","year":"2013","journal-title":"PLoS Genet"},{"key":"2019121022403582500_bib9","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000345670","article-title":"Multiple endocrine neoplasia type 4","volume":"41","author":"Lee","year":"2013","journal-title":"Front Horm Res"},{"issue":"41","key":"2019121022403582500_bib10","doi-asserted-by":"crossref","first-page":"14659","DOI":"10.1073\/pnas.0503484102","article-title":"Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27Kip1 and p18INK4c","volume":"102","author":"Karnik","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"2019121022403582500_bib11","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nrendo.2018.3","article-title":"Current and emerging therapies for PNETs in patients with or without MEN1","volume":"14","author":"Frost","year":"2018","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"2019121022403582500_bib12","doi-asserted-by":"crossref","first-page":"K7","DOI":"10.1530\/EJE-14-0080","article-title":"A heterozygous frameshift mutation in exon 1 of CDKN1B gene in a patient affected by MEN4 syndrome","volume":"171","author":"Tonelli","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"2019121022403582500_bib13","doi-asserted-by":"crossref","first-page":"E1825","DOI":"10.1002\/humu.21354","article-title":"A novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterization","volume":"31","author":"Molatore","year":"2010","journal-title":"Hum Mutat"},{"issue":"3","key":"2019121022403582500_bib14","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1530\/EJE-11-0929","article-title":"Functional characterization of a rare germline mutation in the gene encoding the cyclin-dependent kinase inhibitor p27Kip1 (CDKN1B) in a Spanish patient with multiple endocrine neoplasia-like phenotype","volume":"166","author":"Malanga","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"2019121022403582500_bib15","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1210\/jc.2006-2843","article-title":"Germline CDKN1B\/p27Kip1 mutation in multiple endocrine neoplasia","volume":"92","author":"Georgitsi","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019121022403582500_bib16","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10549-015-3674-y","article-title":"Identification of six pathogenic RAD51C mutations via mutational screening of 1228 Danish individuals with increased risk of hereditary breast and\/or ovarian cancer","volume":"155","author":"J\u00f8nson","year":"2016","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"2019121022403582500_bib17","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jmoldx.2016.10.002","article-title":"Standards and guidelines for the interpretation and reporting of sequence variants in cancer: a joint consensus recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists","volume":"19","author":"Li","year":"2017","journal-title":"J Mol Diagn"},{"issue":"4","key":"2019121022403582500_bib18","doi-asserted-by":"crossref","first-page":"E701","DOI":"10.1210\/jc.2010-1338","article-title":"Somatic mutation and germline sequence abnormalities in CDKN1B, encoding p27Kip1, in sporadic parathyroid adenomas","volume":"96","author":"Costa-Guda","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2019121022403582500_bib19","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1365-2265.2011.04269.x","article-title":"Novel mutations in MEN1, CDKN1B and AIP genes in patients with multiple endocrine neoplasia type 1 syndrome in Spain","volume":"76","author":"Belar","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2019121022403582500_bib20","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/gim.2014.89","article-title":"Whole-exome sequencing identifies rare pathogenic variants in new predisposition genes for familial colorectal cancer","volume":"17","author":"Esteban-Jurado","year":"2015","journal-title":"Genet Med"},{"issue":"3","key":"2019121022403582500_bib21","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1530\/ERC-11-0362","article-title":"Cyclin-dependent kinase inhibitor 1B (CDKN1B) gene variants in AIP mutation-negative familial isolated pituitary adenoma kindreds","volume":"19","author":"Tichomirowa","year":"2012","journal-title":"Endocr Relat Cancer"},{"key":"2019121022403582500_bib22","first-page":"510985","article-title":"Early onset primary hyperparathyroidism associated with a novel germline mutation in CDKN1B","volume":"2015","author":"Elston","year":"2015","journal-title":"Case Rep Endocrinol"},{"key":"2019121022403582500_bib23","first-page":"bcr2015213934","article-title":"Uncommon association of cerebral meningioma, parathyroid adenoma and papillary thyroid carcinoma in a patient harbouring a rare germline variant in the CDKN1B gene","volume-title":"BMJ Case Rep","author":"Bugalho","year":"2016"},{"issue":"1","key":"2019121022403582500_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EC-14-0116","article-title":"Functional characterization of a CDKN1B mutation in a Sardinian kindred with multiple endocrine neoplasia type 4 (MEN4)","volume":"4","author":"Pardi","year":"2015","journal-title":"Endocr Connect"},{"issue":"1","key":"2019121022403582500_bib25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.beem.2006.12.004","article-title":"Surgery on neuroendocrine tumours","volume":"21","author":"Akerstr\u00f6m","year":"2007","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"9","key":"2019121022403582500_bib26","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1210\/JC.2015-2015","article-title":"Long-term natural course of pituitary tumors in patients with MEN1: results from the DutchMEN1 Study Group (DMSG)","volume":"100","author":"de Laat","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2019121022403582500_bib27","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1210\/jc.2010-1048","article-title":"Pituitary incidentaloma: an endocrine society clinical practice guideline","volume":"96","author":"Freda","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2019121022403582500_bib28","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1046\/j.1365-2796.1998.00281.x","article-title":"Management of the Zollinger-Ellison syndrome in patients with multiple endocrine neoplasia type 1","volume":"243","author":"Jensen","year":"1998","journal-title":"J Intern Med"},{"issue":"4","key":"2019121022403582500_bib29","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/PAS.0b013e31815ade45","article-title":"Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients","volume":"32","author":"Trouillas","year":"2008","journal-title":"Am J Surg Pathol"},{"issue":"14","key":"2019121022403582500_bib30","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1101\/gad.1556607","article-title":"Discovery of an oncogenic activity in p27Kip1 that causes stem cell expansion and a multiple tumor phenotype","volume":"21","author":"Besson","year":"2007","journal-title":"Genes Dev"},{"issue":"21","key":"2019121022403582500_bib31","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.4161\/cc.8.21.9789","article-title":"p27 as Jekyll and Hyde: regulation of cell cycle and cell motility","volume":"8","author":"Larrea","year":"2009","journal-title":"Cell Cycle"},{"issue":"9","key":"2019121022403582500_bib32","first-page":"4371","article-title":"Somatic mutations in MEN type 1 tumors, consistent with the Knudson \u201ctwo-hit\u201d hypothesis","volume":"86","author":"Pannett","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"6707","key":"2019121022403582500_bib33","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/24179","article-title":"The murine gene p27Kip1 is haplo-insufficient for tumour suppression","volume":"396","author":"Fero","year":"1998","journal-title":"Nature"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/jc.2019-00082\/28377043\/jc.2019-00082.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/104\/9\/3637\/28952895\/jc.2019-00082.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/104\/9\/3637\/28952895\/jc.2019-00082.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T22:48:45Z","timestamp":1576018125000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/104\/9\/3637\/5450714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,16]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2019-00082","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,9]]},"published":{"date-parts":[[2019,4,16]]}}}